title: Cholestyramine for thyrotoxicosis?
authors.affiliation: Department of Medicine, Pulmonary and Critical Care Medicine, University of Miami, FL, USA. dlin@med.miami.edu
authors.forename: Dagmar
authors.initials: D
authors.lastname: Lin
authors.forename: Nuntra
authors.initials: N
authors.lastname: Suwantarat
authors.forename: Michael
authors.initials: M
authors.lastname: Bornemann
mesh_terms: D000328:Adult; D013956:Antithyroid Agents / Q000627:therapeutic use*; D002792:Cholestyramine Resin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D013971:Thyrotoxicosis / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
chemical_list: D013956:Antithyroid Agents; D016898:Interferon-alpha; D002792:Cholestyramine Resin